John Karijolich

Vanderbilt University Medical Center

$5,446,739

Attributed

$5,446,739

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY2020–25

$2M$1.5M$1M$500K$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,446,739 · 3

By mechanism

R01$5,446,739 · 3

Top collaborators

No co-investigators on record.

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Eric P Skaar$39,454,498
Yuval Dor$525,377
Erez Levanon$525,377

Others in their field

Other Emerging Leaders on “Disease Progression”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Beth Baseler · Leidos Biomedical Research, Inc.$111,936,677
Klaus Romero · Critical Path Institute$90,404,592
Susan Abushakra · Alzheon, Inc.$47,265,244
John Damon Chodera · Sloan-Kettering Inst Can Research$45,424,821
Ryan Cirz · Revagenix, Inc.$40,209,479

Research focus

Disease ProgressionExperimental StudyVirusCellsRegulationMediatingEtiologyTranscriptomeHuman Herpesvirus 8Malignant NeoplasmsPathway InteractionsKaposi SarcomaPrimary Effusion LymphomaProteinsAcquired Immunodeficiency SyndromeB-LymphocytesHerpesviridae InfectionsGenetic TranscriptionProductionInfectionFamilyLytic PhaseCancer EtiologyLytic